Dongguan Boyang E-commerce Co., Ltd – Trademark Portfolio

Entity Type: 16

Dongguan Boyang E-commerce Co., Ltd holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include INZILOTEX. The owner is based in Dongguan, Guangdong.

Room 402, No. 9

Chulong Er Xiang, Humen Town

Dongguan, Guangdong 523165 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Dongguan Boyang E-commerce Co., Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (2 filings)

Clothing, footwear, headgear

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Dongguan Boyang E-commerce Co., Ltd have?

Dongguan Boyang E-commerce Co., Ltd has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered.

What trademark classes does Dongguan Boyang E-commerce Co., Ltd file in?

Dongguan Boyang E-commerce Co., Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 10 (Medical Apparatus). Class 25 covers clothing, footwear, headgear.

What are Dongguan Boyang E-commerce Co., Ltd's most well-known trademarks?

Dongguan Boyang E-commerce Co., Ltd's registered trademark portfolio includes well-known marks such as INZILOTEX. These are among 1 currently registered trademark in the portfolio.

What is Dongguan Boyang E-commerce Co., Ltd's trademark registration success rate?

Dongguan Boyang E-commerce Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.